51-77-4

• 常用中文名：吉法酯
• 常用英文名：Gefarnate
• CAS号：51-77-4
• 分子式：C₂₇H₄₄O₂
• 分子量：400.637
• 相关类别： 原料药 消化系统用药 胃肠解痉药
• 发布时间：2018-07-19 15:44:47
• 更新时间：2024-01-04 20:26:25
• Gefarnate 是一种治疗胃炎和胃溃疡的药物,目前也用于干眼症的研究。

名称

• 中文名: 吉法酯
• 英文名: [(2E)-3,7-dimethylocta-2,6-dienyl] (4E,8E)-5,9,13-trimethyltetradeca-4,8,12-trienoate
• 中文别名: [(2E)-3,7-二甲基辛-2,6-二烯基] (4E,8E)-5,9,13-三甲基十四碳-4,8,12-三烯酸酯
• 英文别名: Gepharnate; arsanyl; (2E)-3,7-Dimethylocta-2,6-dien-1-yl (4E,8E)-5,9,13-trimethyltetradeca-4,8,12-trienoate; Gefanil; Gefarnate [INN:BAN:JAN]; (E)-Geranyl (E,E)-farnesylacetate; Gefarnyl; Osteol; EINECS 200-121-0; trans-(4,5),trans-(8,9)-Farnesylessigsaeure-geranylester; Gefarnate; (2E)-3,7-Dimethyl-2,6-octadien-1-yl (4E,8E)-5,9,13-trimethyl-4,8,12-tetradecatrienoate; (4E,8E)-5,9,13-trimethyltetradeca-4,8,12-trienoic acid [(2E)-3,7-dimethylocta-2,6-dienyl] ester; DA-688; Gefarnato [INN-Spanish]; Geranyl farnesylacetate; 5,9,13-Trimethyl-4,8,12-tetradecatrienoic acid 3,7-dimethyl-2,6-octadienyl ester; (4E,8E)-Farnesylacetic acid geranyl ester; Gefarnil; Gefarnatum [INN-Latin]; 4,8,12-Tetradecatrienoic acid, 5,9,13-trimethyl-, (2E)-3,7-dimethyl-2,6-octadien-1-yl ester, (4E,8E)-

物化性质

• 密度: 0.9±0.1 g/cm3
• 沸点: 484.7±34.0 °C at 760 mmHg
• 熔点: 25°C
• 分子式: C₂₇H₄₄O₂
• 分子量: 400.637
• 闪点: 93.3±24.0 °C
• 精确质量: 400.334137
• PSA: 26.30000
• LogP: 10.53
• 蒸汽压: 0.0±1.2 mmHg at 25°C
• 折射率: 1.489
• 储存条件: 室温，干燥

生物活性

• 描述: Gefarnate 是一种治疗胃炎和胃溃疡的药物,目前也用于干眼症的研究。
• 相关类别:
  信号通路 >> 其他 >> 其他
  研究领域 >> 炎症/免疫
• 体外研究: Gefarnate(0.001,0.01或0.1 mg/mL)以剂量依赖的方式增加粘蛋白样糖蛋白分泌,但与对照的差异仅在0.1 mg/mL的浓度下显着。 Gefarnate特异性刺激粘蛋白样糖蛋白分泌[1]。
• 参考文献:

  [1]. Nakamura M, et al. Gefarnate stimulates secretion of mucin-like glycoproteins by corneal epithelium in vitro and protects corneal epithelium from desiccation in vivo. Exp Eye Res. 1997 Oct;65(4):569-74.

毒性和生态

CHEMICAL IDENTIFICATION RTECS NUMBER : XB8890000 CHEMICAL NAME : 4,8,12-Tetradecatrienoic acid, 5,9,13-trimethyl-, 3,7-dimethyl-2,6-octadienyl ester, (E,E,E)- CAS REGISTRY NUMBER : 51-77-4 LAST UPDATED : 199701 DATA ITEMS CITED : 8 MOLECULAR FORMULA : C27-H44-O2 MOLECULAR WEIGHT : 400.71 WISWESSER LINE NOTATION : 1Y1&U3Y1&U3Y1&U3VO2UY1&3UY1&1 HEALTH HAZARD DATA ACUTE TOXICITY DATA TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rat DOSE/DURATION : >9 gm/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,266,1982 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 2040 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,266,1982 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intramuscular SPECIES OBSERVED : Rodent - rat DOSE/DURATION : >13500 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,266,1982 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : >8 gm/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : JMCMAR Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- Volume(issue)/page/year: 6,457,1963 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : >4 gm/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : JMCMAR Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- Volume(issue)/page/year: 6,457,1963 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 2821 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : JMCMAR Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- Volume(issue)/page/year: 6,457,1963 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intramuscular SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : >13500 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,266,1982

合成路线

80868-14-0 ~75% 51-77-4

文献：Sato; Inoue; Sakamoto Synthesis, 1981 , vol. No.10, p. 796 - 798

106-24-1 ~% 51-77-4

文献：Sato; Inoue; Sakamoto Synthesis, 1981 , vol. No.10, p. 796 - 798

24163-93-7 ~% 51-77-4

文献：Sato; Inoue; Sakamoto Synthesis, 1981 , vol. No.10, p. 796 - 798

60758-60-3 ~% 51-77-4

文献：Sato; Inoue; Sakamoto Synthesis, 1981 , vol. No.10, p. 796 - 798

80868-13-9 ~% 51-77-4

文献：Sato; Inoue; Sakamoto Synthesis, 1981 , vol. No.10, p. 796 - 798

106-24-1 26732-80-9 ~% 30462-48-7 51-77-4

文献：Nigmatov, A. G.; Serebryakov, E. P.; Yanovskaya, L. A. Pharmaceutical Chemistry Journal, 1987 , vol. 21, # 7 p. 529 - 533 Khimiko-Farmatsevticheskii Zhurnal, 1987 , vol. 21, # 7 p. 854 - 858

上下游产品

上游产品  5
80868-14-0 106-24-1 24163-93-7 60758-60-3
80868-13-9
下游产品  0